Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This authorization permits its use for active immunization to prevent COVID-19 in individuals aged 12 and […]
A recent study published in BMJ Public Health has sparked controversy by suggesting that COVID-19 vaccines may have contributed to a rise in excess deaths in the United States and other Western countries during the three years since the pandemic began. The research, conducted by scientists from Vrije Universiteit in the Netherlands, analyzed mortality data […]
In a significant development, UK-based pharmaceutical giant AstraZeneca has announced the global withdrawal of its COVID-19 vaccine, known as Covishield in India and Vaxzevria in other markets. This decision comes shortly after the company admitted in court documents that the vaccine could cause a rare but severe side effect known as Thrombosis Thrombocytopenia Syndrome (TTS). […]
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series of interactions with the Indian drug regulator, which had requested additional information regarding the vaccine. Regulatory Hurdles and Safety Concerns Initially submitted for approval in December 2020, the application faced […]